HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chromosome aberrations in peripheral lymphocytes of patients irradiated with 15-MeV-photons for Morbus Hodgkin.

Abstract
Chromosome aberrations in peripheral lymphocytes of two Morbus Hodgkin patients were analyzed before and during the ongoing radiotherapy. Venous blood was taken 5 min after and before a successive irradiation in order to examine the dose dependence as well as the influence of mixed unirradiated and irradiated lymphocytes on the aberration rate. Both patients showed an overdispersed distribution of dicentric chromosomes and acentric fragment from the outset of therapy and independent of the time blood was taken. The dose-effect relationship established for both types of aberrations by the Maximum-Likelihood approach may best be described as being linear. The dose effect curves 5 min after a fraction did not differ from those calculated for a time thereafter. However, after the first two irradiations, the rate of dicentric chromosomes in the blood samples taken at a later time was about twice as high as that in the samples taken 5 min after irradiation. Dicentric chromosomes were twice more frequent during the entire radiotherapy than acentric fragments and about 30 times more frequent than centric ring chromosomes.
AuthorsG Stephan, A Diener, T Vogl
JournalStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (Strahlenther Onkol) Vol. 166 Issue 7 Pg. 460-5 (Jul 1990) ISSN: 0179-7158 [Print] Germany
PMID2116675 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Adult
  • Chromosome Aberrations
  • Chromosomes (radiation effects)
  • Dose-Response Relationship, Radiation
  • Female
  • Hodgkin Disease (genetics, radiotherapy)
  • Humans
  • Lymphocytes (radiation effects)
  • Male
  • Radiotherapy, High-Energy (adverse effects)
  • Ring Chromosomes

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: